ticlopidine has been researched along with Bone Neoplasms in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Various strategies are emerging for dosing antiplatelet therapies in preparation for pipeline stent embolization in adults." | 2.55 | Optimal pediatric dosing of anti-platelet agents for pipeline stent embolization -a case report and review of the literature. ( Cobb, MIH; Fernando Gonzalez, L; Hauck, EF; Smith, TP; Zomorodi, AR, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cobb, MIH | 1 |
| Zomorodi, AR | 1 |
| Hauck, EF | 1 |
| Smith, TP | 1 |
| Fernando Gonzalez, L | 1 |
| Su, X | 1 |
| Floyd, DH | 1 |
| Hughes, A | 1 |
| Xiang, J | 1 |
| Schneider, JG | 1 |
| Uluckan, O | 1 |
| Heller, E | 1 |
| Deng, H | 1 |
| Zou, W | 1 |
| Craft, CS | 1 |
| Wu, K | 1 |
| Hirbe, AC | 1 |
| Grabowska, D | 1 |
| Eagleton, MC | 1 |
| Townsley, S | 1 |
| Collins, L | 1 |
| Piwnica-Worms, D | 1 |
| Steinberg, TH | 1 |
| Novack, DV | 1 |
| Conley, PB | 1 |
| Hurchla, MA | 1 |
| Rogers, M | 1 |
| Weilbaecher, KN | 1 |
1 review available for ticlopidine and Bone Neoplasms
| Article | Year |
|---|---|
Optimal pediatric dosing of anti-platelet agents for pipeline stent embolization -a case report and review of the literature.
Topics: Adolescent; Aspirin; Bone Neoplasms; Cerebral Hemorrhage; Clopidogrel; Embolization, Therapeutic; Fe | 2017 |
1 other study available for ticlopidine and Bone Neoplasms
| Article | Year |
|---|---|
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.
Topics: Adenosine Diphosphate; Animals; Arthritis, Experimental; Bone Neoplasms; Bone Remodeling; Bone Resor | 2012 |